Eric Coffman
Addiction Medicine · Bloomfield, MINPI 1457469330
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $786 and has fallen 98.0% since, to $16 in 2023.
Across 151 payments — averaging $16.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$455
- Gilead$410
- AbbVie$385
- Neurocrine Biosciences, Inc.$228
- USWM, LLC$199
- MDD US Operations, LLC$170
- plus $688 from 16 others
What the payments were for
- Food & beverage$2,535100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 32 | $455 |
| Gilead | 20 | $410 |
| AbbVie(2 entities) | 24 | $385 |
| Neurocrine Biosciences, Inc. | 9 | $228 |
| USWM, LLC | 12 | $199 |
| MDD US Operations, LLC | 14 | $170 |
| Orexo US, Inc. | 11 | $166 |
| Boehringer Ingelheim | 5 | $110 |
| Sunovion Pharmaceuticals Inc. | 5 | $106 |
| Zyla Life Sciences, Inc. | 4 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| GSK | 2 | $30 |
| Indivior Inc. | 2 | $27 |
| Amgen | 1 | $24 |
| Biohaven Pharmaceuticals, Inc. | 1 | $23 |
| Idorsia Pharmaceuticals US Inc | 1 | $22 |
| Kaleo, Inc. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Pfizer | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| AstraZeneca | 1 | $13 |
| Supernus Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$2,535 in reported general payments places this provider in the 80th percentile of 62 addiction medicine providers in Michigan.
Other addiction medicine in Bloomfield
- Alta DerooKalamazoo$53K
- Michael FoxLivonia$39K
- William MorroneEssexville$17K
- Timothy GammonsSterling Heights$9K
- John CampbellKentwood$8K
- Arun GuptaMonroe$5K
- Morgan FoxLivonia$5K
- Jaswant BaggaAuburn Hills$4K
- Robert McMorrowHoughton Lake$3K
- Yasmin KeshavjeeWarren$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.